GBIO Generation Bio Co

Price (delayed)

$31.72

Market cap

$1.8B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.69

Enterprise value

$1.48B

Sector: Healthcare
Industry: Biotechnology

Highlights

The quick ratio has soared by 185% YoY and by 78% from the previous quarter
Generation Bio's EPS has soared by 79% YoY and by 9% from the previous quarter
The net income has contracted by 36% YoY and by 10% from the previous quarter

Key stats

What are the main financial stats of GBIO
Market
Shares outstanding
56.63M
Market cap
$1.8B
Enterprise value
$1.48B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.9
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$88.37M
EBITDA
-$84.55M
Free cash flow
-$79.81M
Per share
EPS
-$2.69
Free cash flow per share
-$1.44
Book value per share
$8.13
Revenue per share
$0
TBVPS
$9.29
Balance sheet
Total assets
$514.08M
Total liabilities
$55.35M
Debt
$48.77M
Equity
$458.74M
Working capital
$444.99M
Liquidity
Debt to equity
0.11
Current ratio
42.23
Quick ratio
41.98
Net debt/EBITDA
3.78
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-24.4%
Return on equity
-26.8%
Return on invested capital
-44.6%
Return on capital employed
-17.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GBIO stock price

How has the Generation Bio stock price performed over time
Intraday
2.49%
1 week
-1.98%
1 month
19.34%
1 year
N/A
YTD
11.89%
QTD
11.45%

Financial performance

How have Generation Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$88.73M
Net income
-$88.37M
Gross margin
N/A
Net margin
N/A
The net income has contracted by 36% YoY and by 10% from the previous quarter
Generation Bio's operating income has decreased by 35% YoY and by 9% QoQ

Growth

What is Generation Bio's growth rate over time

Valuation

What is Generation Bio stock price valuation
P/E
N/A
P/B
3.9
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Generation Bio's EPS has soared by 79% YoY and by 9% from the previous quarter
The equity has soared by 71% QoQ
The P/B is 7% below the last 4 quarters average of 4.1

Efficiency

How efficient is Generation Bio business performance
Generation Bio's ROIC has soared by 86% YoY and by 13% from the previous quarter
The ROA has soared by 50% YoY and by 19% from the previous quarter
Generation Bio's ROE has increased by 38% from the previous quarter

Dividends

What is GBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GBIO.

Financial health

How did Generation Bio financials performed over time
The quick ratio has soared by 185% YoY and by 78% from the previous quarter
The current ratio has soared by 179% year-on-year and by 77% since the previous quarter
Generation Bio's debt is 89% less than its equity
The equity has soared by 71% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.